- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Public Companies
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Forever Chemicals (PFAS)
Insights 18 results
Newsletter
January 25, 2022
Focus on Forever– January 25, 2022
Newsletter
January 12, 2022
Focus on Forever– January 11, 2022
Newsletter
December 13, 2021
Focus on Forever– December 13, 2021
Newsletter
November 16, 2021
Focus on Forever - November 16, 2021
Newsletter
November 2, 2021
Focus on Forever - November 2, 2021
Client Alert
October 21, 2021
EPA’s PFAS Strategic Roadmap Sets Broad and Ambitious Goals
Client Alert
October 20, 2021
US EPA Issues Draft Strategic Plan
Newsletter
October 19, 2021
Focus on Forever – October 19, 2021
Newsletter
August 25, 2021
International Food Law Gazette – August 2021
Client Alert
June 16, 2021
EPA Issues Expansive Proposed PFAS Reporting Rule for Manufactured and Imported Goods
Article · Source: Law360
May 27, 2021
What EPA's Environmental Justice Push Means For Cos.